Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Summary of Basic and Diluted Net Loss Per Share

Basic and diluted net loss per share was calculated as follows (in thousands, except share and per share amounts):

	Year Ended December 31,
	2024			2023
Numerator:
Net loss	$	(77,331	)	$	(73,790	)
Denominator:
Weighted-average common shares outstanding, basic and diluted		58,445,765			39,904,603
Net loss per share, basic and diluted	$	(1.32	)	$	(1.85	)

Anti-Dilutive Effect Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders

The following potentially dilutive securities have been excluded from the calculation of diluted net loss per common share due to their anti-dilutive effect:

	December 31,
	2024		2023
Stock options outstanding		9,711,075		5,982,464
Non-vested and unsettled restricted stock units		2,463,601		3,631,431
Shares reserved for future issuance		4,295,342		1,013,840
Apexigen replacement warrants		1,003,191		1,003,191
Employee stock purchase plan		573,316		565,405
Total		18,046,525		12,196,331